DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Betadine (Povidone-Iodine Ophthalmic) - Rash Maculo-Papular - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Rash Maculo-Papular (4)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Betadine (Povidone-Iodine Ophthalmic) where reactions include rash maculo-papular. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Betadine side effects in male

Reported by a physician from France on 2012-07-13

Patient: male

Reactions: Rash Maculo-Papular, Dermatitis Exfoliative, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Phenylephrine HCL
    Indication: Cataract Operation
    Start date: 2012-06-07
    End date: 2012-06-07

Diclofenac
    Indication: Cataract Operation
    Start date: 2012-06-07
    End date: 2012-06-07

Carbocaine
    Dosage: 0.4 grams/ 20 ml
    Indication: Cataract Operation
    Start date: 2012-06-07
    End date: 2012-06-07

Levofloxacin
    Administration route: Oral
    Indication: Cataract Operation
    Start date: 2012-06-06
    End date: 2012-06-07

Dexamethasone
    Indication: Cataract Operation
    Start date: 2012-06-07
    End date: 2012-06-07

Betadine
    Indication: Cataract Operation
    Start date: 2012-06-07
    End date: 2012-06-07

Diamox
    Indication: Cataract Operation
    Start date: 2012-06-07
    End date: 2012-06-07

Tropicamide
    Indication: Cataract Operation
    Start date: 2012-06-07
    End date: 2012-06-07

Other drugs received by patient: Desloratadine; Spiriva; Digoxin; Levothyroxine Sodium; Furosemide; Allopurinol; Humera; Symbicort; Ramipril; Amlodipine Besylate; Bricanyl; Fenofibrate; Aspirin; Amiodarone HCL



Possible Betadine side effects in 71 year old female

Reported by a health professional (non-physician/pharmacist) on 2012-06-06

Patient: 71 year old female

Reactions: Viral Rash, Idiopathic Urticaria, Post Procedural Complication, Type III Immune Complex Mediated Reaction, Rash Pruritic, Rash Erythematous, Rash Maculo-Papular, Toxic Skin Eruption

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Plavix
    Dosage: (1 in 1 d)
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-08-22

Tocopheryl Acetate (Tocopheryl Acetate)
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-08-21
    End date: 2009-08-21

Solu-Medrol
    Indication: Premedication
    Start date: 2009-08-21
    End date: 2009-08-21

Lovenox
    Dosage: subcutaneous
    Indication: Premedication
    Start date: 2009-08-21
    End date: 2009-08-21

Repaglinide
    Dosage: 1.5 mg (1.5 mg,1 in 1 d),oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-08-22
    End date: 2009-08-28

Visipaque
    Dosage: intravenous
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-08-21
    End date: 2009-08-21

Metformin HCL
    Dosage: 500 mg thrice/day (500 mg,3 in 1 d),oral
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2009-08-22
    End date: 2009-08-28

Isosorbide Dinitrate
    Indication: Premedication
    Start date: 2009-08-21
    End date: 2009-08-21

Betadine
    Dosage: topical
    Administration route: Topical
    Indication: Infection Prophylaxis
    Start date: 2009-08-21
    End date: 2009-08-21

Isoptin
    Indication: Premedication
    Start date: 2009-08-21
    End date: 2009-08-21

Aspirin
    Dosage: (1 in 1 d),oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-08-22

Amlodipine Besylate
    Dosage: (1 in 1 d),oral
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-08-22

Other drugs received by patient: Nordaz (Nordazepam); Havlane (Loprazolam Mesilate); Januvia (Sitaglipitn Phosphate); Ebastine; Daflon (Diosmin); Aerius (Ebastine); Polyethylene Glycol



Possible Betadine side effects in 71 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-31

Patient: 71 year old female

Reactions: Pruritus, Rash Erythematous, Rash Maculo-Papular

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Isosorbide Dinitrate
    Dosage: unk
    Indication: Premedication
    Start date: 2009-08-21
    End date: 2009-08-21

Tocopheryl Acetate
    Dosage: unk
    Start date: 2009-08-21
    End date: 2009-08-21

Isoptin
    Dosage: unk
    Indication: Premedication
    Start date: 2009-08-21
    End date: 2009-08-21

Repaglinide
    Dosage: 1.5 mg, 1x/day
    Administration route: Oral
    Start date: 2009-08-22
    End date: 2009-08-28

Aspirin
    Dosage: 160 mg, 1x/day
    Administration route: Oral
    Start date: 2009-08-22

Amlodipine Besylate
    Dosage: 10 mg, 1x/day
    Administration route: Oral
    Start date: 2009-08-22

Plavix
    Dosage: 75 mg, 1x/day
    Administration route: Oral
    Start date: 2009-08-22

Metformin HCL
    Dosage: 500 mg, 3x/day
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2009-08-22
    End date: 2009-08-28

Betadine
    Dosage: unk
    Administration route: Topical
    Indication: Infection Prophylaxis
    Start date: 2009-08-21
    End date: 2009-08-21

Visipaque
    Dosage: unk
    Start date: 2009-08-21
    End date: 2009-08-21

Lovenox
    Dosage: unk
    Indication: Premedication
    Start date: 2009-08-21
    End date: 2009-08-21

Solu-Medrol
    Dosage: unk
    Indication: Premedication
    Start date: 2009-08-21
    End date: 2009-08-21

Other drugs received by patient: Daflon; Januvia; Ebastine; Havlane; Polyethylene Glycol; Desloratadine; Nordaz



Possible Betadine side effects in 71 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-31

Patient: 71 year old female

Reactions: Pruritus, Idiopathic Urticaria, Rash Erythematous, Urticaria, Rash Maculo-Papular

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Metformin HCL
    Dosage: 500 mg, tid, unk
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    Start date: 2009-08-22
    End date: 2009-08-28

Heparin
    Dosage: unk
    Start date: 2009-08-21
    End date: 2009-08-21

Visipaque
    Dosage: unk
    Start date: 2009-08-21
    End date: 2009-08-21

Betadine
    Dosage: unk
    Start date: 2009-08-21
    End date: 2009-08-21

Repaglinide
    Dosage: 0.5 mg, tid , unk
    Administration route: Oral
    Start date: 2009-08-22
    End date: 2009-08-28

Aspirin
    Dosage: 160.000000 mg, qd, unk
    Administration route: Oral
    Start date: 2009-08-22

Clopidogrel Bisulfate
    Dosage: 75.000000 mg, qd, unk
    Administration route: Oral
    Start date: 2009-08-22

Tocopheryl Acetate
    Dosage: unk
    Start date: 2009-08-21
    End date: 2009-08-21

Isoptin
    Dosage: unk
    Start date: 2009-08-21
    End date: 2009-08-21

Solu-Medrol
    Dosage: unk
    Start date: 2009-08-21
    End date: 2009-08-21

Amlodipine Besylate
    Dosage: 10 mg, qd , unk
    Administration route: Oral
    Start date: 2009-08-22

Other drugs received by patient: Daflon; Ebastine; Loprazolam Mesilate; Macrogol

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017